Zdrowie i gospodarka · 31/05/2016
FDA Corrects Notice on Clinical Trial Design for Malaria Drug Development
The FDA is correcting a notice that appeared in the Federal Register on May 10, 2016, due to errors in the title and internet address of a public workshop on clinical trial design for malaria drug development.
Source: Federal Register — Food and Drug AdministrationOpen original release →